Carter HB - Search Results

1

Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.

Epstein JI, Chan DW, Sokoll LJ, Walsh PC, Cox JL, Rittenhouse H, Wolfert R, Carter HB. Epstein JI, et al. Among authors: carter hb. J Urol. 1998 Dec;160(6 Pt 2):2407-11. J Urol. 1998. PMID: 9817393 Free article. Review.

2

Expectant management of nonpalpable prostate cancer with curative intent: preliminary results.

Carter HB, Walsh PC, Landis P, Epstein JI. Carter HB, et al. J Urol. 2002 Mar;167(3):1231-4. J Urol. 2002. PMID: 11832703

3

Can prostate specific antigen derivatives and pathological parameters predict significant change in expectant management criteria for prostate cancer?

Khan MA, Carter HB, Epstein JI, Miller MC, Landis P, Walsh PW, Partin AW, Veltri RW. Khan MA, et al. Among authors: carter hb. J Urol. 2003 Dec;170(6 Pt 1):2274-8. doi: 10.1097/01.ju.0000097124.21878.6b. J Urol. 2003. PMID: 14634395

4

Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer.

Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Allaf ME, et al. Among authors: carter hb. J Urol. 2004 Nov;172(5 Pt 1):1840-4. doi: 10.1097/01.ju.0000140912.45821.1d. J Urol. 2004. PMID: 15540734

5

Radical retropubic prostatectomy. How often do experienced surgeons have positive surgical margins when there is extraprostatic extension in the region of the neurovascular bundle?

Hernandez DJ, Epstein JI, Trock BJ, Tsuzuki T, Carter HB, Walsh PC. Hernandez DJ, et al. Among authors: carter hb. J Urol. 2005 Feb;173(2):446-9. doi: 10.1097/01.ju.0000151135.80249.c9. J Urol. 2005. PMID: 15643199

6

Utility of saturation biopsy to predict insignificant cancer at radical prostatectomy.

Epstein JI, Sanderson H, Carter HB, Scharfstein DO. Epstein JI, et al. Among authors: carter hb. Urology. 2005 Aug;66(2):356-60. doi: 10.1016/j.urology.2005.03.002. Urology. 2005. PMID: 16040085

7

Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.

Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML. Magheli A, et al. Among authors: carter hb. J Urol. 2007 Oct;178(4 Pt 1):1277-80; discussion 1280-1. doi: 10.1016/j.juro.2007.05.153. Epub 2007 Aug 14. J Urol. 2007. PMID: 17698121

8

Expectant management of prostate cancer with curative intent: an update of the Johns Hopkins experience.

Carter HB, Kettermann A, Warlick C, Metter EJ, Landis P, Walsh PC, Epstein JI. Carter HB, et al. J Urol. 2007 Dec;178(6):2359-64; discussion 2364-5. doi: 10.1016/j.juro.2007.08.039. Epub 2007 Oct 22. J Urol. 2007. PMID: 17936806 Free PMC article.

9

Change in prostate cancer grade over time in men followed expectantly for stage T1c disease.

Sheridan TB, Carter HB, Wang W, Landis PB, Epstein JI. Sheridan TB, et al. Among authors: carter hb. J Urol. 2008 Mar;179(3):901-4; discussion 904-5. doi: 10.1016/j.juro.2007.10.062. Epub 2008 Jan 22. J Urol. 2008. PMID: 18207195 Free PMC article.

10

A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.

Osunkoya AO, Carter HB, Epstein JI. Osunkoya AO, et al. Among authors: carter hb. Urology. 2008 Sep;72(3):638-40. doi: 10.1016/j.urology.2008.01.004. Epub 2008 Apr 8. Urology. 2008. PMID: 18400278

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

305 results

Search Page

Filters